Medicines and Healthcare products Regulatory Agency

An executive agency, also called MHRA

The National Institute for Biological Standards and Control (NIBSC) is part of the Medicines and Healthcare products Regulatory Agency.

570 requests
Dear Mr MacArthur, Please find attached the response to your FOIA internal review request. Kind regards,   FOI Team Vigilance and Risk Management of...
FOI 21/483   Dear D Schofiel,   Thank you for your communication to the MHRA in relation to a Freedom of Information request for:   1. The...
FOI 21/096 Dear Flora Nisbet, Thank you for your email. We confirm we have published the data and this is available to view at the following link of...
FOI 21/088 Dear Eyerusalem Chaka, Thank you for your email. We confirm we have published the data and this is available to view at the following lin...
FOI 21/029 Dear Karl Rainer, Thank you for your email of the 11th January where you have asked “Please can you provide weekly data for the number of...
FOI 21/509   Dear Andrew Anderson,   Thank you for your email.   We do receive funding from the Bill and Melinda Gates Foundation as well...
FOI 21/393   Dear Kristina   Thank you for your email of 10 April 2021 with your concerns on the use of ethylene oxide to sterilise swabs used...
FOI 21/001   Dear Mr Richings,   Thank you for your email.   The authorisation of the Pfizer/BioNTech and the Oxford/AstraZeneca vaccines was do...
Dear Mr Kenyon, Please find attached the response to your FOI request. Kind regards,   FOI Team Vigilance and Risk Management of Medicines Di...
FOI 21/433 Dear Mark Felt, Thank you for your communication to the MHRA in relation to a Freedom of Information request for: Question 1. What is the...
FOI 21/358 Dear AMCBA, Thank you for your email. Please find below the answers to the questions you have raised. QUESTION: Please kindly provide...
Dear Ms Francis, Please find attached the response to your FOI request. Kind regards,   FOI Team Vigilance and Risk Management of Medicines Division...
Dear Ms Frances, Please find attached the response to your FOI request. Kind regards, FOI Team Vigilance and Risk Management of Medicines Division...
northern Ireland Protocol

Partially successful.

FOI 21/316   Dear Abdul Hai   Thank you for your information request, dated 30 March 2021, where you asked, ‘Can you publish any planning or p...
Dear John Watts,   FOI 21/295   Thank you for your communication to the MHRA in relation to a Freedom of Information request for:   1.Plea...
FOI 21/311   Dear Mr Roberts,   Thank you for your email.   With regards to your questions: Please could you inform the public of the min...
FOI 21/287   Dear Henry Speight,   Thank you for your information request, dated 23/03/2021, where you asked for spend by the MHRA on Ernst an...
Thank you for your email.   The Pharmacovigilance Service Team will aim to provide a response to your query within seven working days – however wher...
Dear Mr D Wilson, Thank you for your email and we apologise for delay in response. The Human Medicines Regulations 2012 only addresses the parentera...
FOI 21/302   Dear Molly Kingsley   Thank you for your enquiry of 25 March 2021 relating to the safety of ethylene oxide (EO) and its use to st...
FOI 18/483 Dear Mr Gasson, Thank you for your email. Please find attached the response to your FOI request. Kind Regards Customer Services Commun...
FOI 21/231   Dear Jack Hodgson,   Thank you for your email.   Please find below answers to the questions you have raised.   1- Can you...
FOI 21/192   Dear Mr K. Glavini,   Thank you for your information request, dated 18 February 2021 where you asked for the following: 1.      Elec...
Dear Till Bruckner, Please find attached the response to your FOI request. Kind regards,   FOI Team Vigilance and Risk Management of Medicines Divisi...
Thank you for your email.   The Pharmacovigilance Service Team will aim to provide a response to your query within seven working days – however wher...

Only requests made using WhatDoTheyKnow are shown. ?